TECH

SELL

Bio-Techne Corp

Healthcare · Rank #254 · Analyzed Apr 20, 2026

$59.23

Current Price

$18.48

Intrinsic Value

-58.4%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 58.4%

Fair Value Range

Low$3.50

Base (IV)$18.48

High$24.61

Entry Points

Conservative$3.50

Moderate$10.99

Aggressive$18.48

Quality & Moat Breakdown

Return on Equity4.0% → 0/1.0

Debt LevelD/E 17 → 1.0/1.0

Revenue QualityGrowth 13.4%, margin Δ-23.5% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins6.7% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.